Stoop, M.P.

sample protein peptide proteomic sclerosis patient analysis disease group study maldi-tof number spectrometry cerebrospinal method biomarker comparison control fluid concentration identi metabolite cerebrospinal fluid variation csf samples identification mscl patients differentially proteome difference mass spectrometry research level maldi-ft-icr fication measurement result table peptide peaks esi-orbitrap complement p-value neurol spectra chromogranin system csf sample figure height accuracy process masse brain matrix technique sequence database factor experiment abundance marker sclerosis patients peak height chapter plate albumin cerebrospinal fl uid validation value increase clusterin score identi fication maldi-tof /tof serum netherland detection 10-3 maldi validation sample